News & Articles

The serology test promises 100% sensitivity and can help assess patients' immune response to the virus

Best practice to simulate realistic pipe conditions using a Rotating Cylinder Electrode

The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe

The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio

Download this white paper from Sartorius to find out how advanced flow cytometry addresses the challenges and demands of modern drug discovery pipelines

The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment

Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.

Collaboration will enable global development, manufacturing and distribution of the vaccine

These models aim to accelerate treatment development prior to clinical trials

The test will be available for qualified laboratories across the European Union by the end of May

The MicronJet microneedle device to enable the development of a safe, effective and affordable vaccine

Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19

Visitors to the virtual event can also experience continuous production from powders to the finished capsule with the specially developed X-key principle

The German-based biotech company specializes in process development for recombinant vaccines

Free white paper compares the pros and cons of various standard methods

The company is offering technical and scientific support along with supply chain continuity and instrument contributions

Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April

UCL academics are working with Causaly to help accelerate research into the COVID-19 pandemic, including the identification of biomarkers and potential therapeutic agents